Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients

Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients

Background:. This meta-analysis was to determine the association of the cumulative dose of 130/0.4 or 0.42 (hydroxyethyl starch [HES] 130/0.4*) or delta daily fluid balance (i.e., daily fluid balance in HES group over or below control group) with the heterogeneity of risk ratio (RR) for mortality in...

Full description

Bibliographic Details
Main Authors: Peng-Lin Ma, Xiao-Xia Peng, Bin Du, Xiao-Lan Hu, Yi-Chun Gong, Yu Wang, Xiu-Ming Xi
Format: Article
Language:English
Published: Wolters Kluwer 2015-09-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.4103/0366-6999.163387

Internet

http://journals.lww.com/10.4103/0366-6999.163387

Similar Items